Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr. 2008 Aug; 29(4):293-302.
View in:
PubMed
subject areas
Administration, Oral
Adolescent
Adult
Antidepressive Agents
Blood Cell Count
Child
Cognition
Extracellular Signal-Regulated MAP Kinases
Fragile X Syndrome
Humans
Learning
Lithium Carbonate
Pilot Projects
Psychiatric Status Rating Scales
Psychological Tests
Receptors, Metabotropic Glutamate
Thyrotropin
Treatment Outcome
authors with profiles
Elizabeth Berry-Kravis